Tom Hudson, Chief Scientific Officer, AbbVie discusses Convergence and the Future of Medicine with Ian Tomlinson, Chair, Apollo Therapeutics
This recorded session is part of the Lab of the Future premium content section. It is free for registered users. Please register or submit below